B cell: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author")
m (Text replacement - "authorlink1" to "author-link1")
 
(60 intermediate revisions by the same user not shown)
Line 6: Line 6:
==Notable studies==
==Notable studies==
*2018, [[CD24]] expression and B cell maturation shows a novel link with energy metabolism: potential implications for patients with ME/CFS [https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full (Full text)]  
*2018, [[CD24]] expression and B cell maturation shows a novel link with energy metabolism: potential implications for patients with ME/CFS [https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full (Full text)]  
*2016, Extended B cell phenotype in patients with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]: A cross-sectional study<ref name="Mensah, 2016" /> [https://onlinelibrary.wiley.com/doi/full/10.1111/cei.12749 (Full Text)] [[Jonathan Edwards]] comments on: Extended B-cell phenotype in patients with ME/CFS: A cross-sectional study [http://forums.phoenixrising.me/index.php?threads/extended-b-cell-phenotype-in-patients-with-me-cfs-a-cross-sectional-study.41743/#post-674305 (Link)]
*2016, Extended B cell phenotype in patients with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]: A cross-sectional study<ref name="Mensah, 2016" /> [https://onlinelibrary.wiley.com/doi/full/10.1111/cei.12749 (Full Text)] | [[Jonathan Edwards]] comments on: Extended B-cell phenotype in patients with ME/CFS: A cross-sectional study [http://forums.phoenixrising.me/index.php?threads/extended-b-cell-phenotype-in-patients-with-me-cfs-a-cross-sectional-study.41743/#post-674305 (Link)]
*2015, [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome]  
*2015, [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome]  
*2015, [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment]  
*2015, [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment]  
Line 25: Line 25:
==References==
==References==
<references>
<references>
<ref name="Bradley, 2013">{{Citation |last1   = Bradley |first          1  |authorlink1 = |last2   = Ford |first              2  |authorlink2 = |last3   = Bansal |first            3  |authorlink3 = Amolak Bansal  
<ref name="Bradley, 2013">{{Citation | last1 = Bradley | first1 = AS | author-link1 = | last2 = Ford | first2 = B | author-link2 = | last3 = Bansal | first3 = Amolak | author-link3 = Amolak Bansal | title = Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls | journal = Clinical and Experimental Immunology | volume = 172 | issue = 1 | page = 73–80 | date = 2013 | pmid = | doi = 10.1111/cei.12043 }}</ref>
| title   = Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls
<ref name="Mensah, 2016">{{Citation | last1 = Mensah | first1 = Fane | author-link1 = Fane Mensah | last2 = Bansal | first2 = Amolak | author-link2 = Amolak Bansal | last3 = Berkovitz | first3 = Saul | author-link3 = Saul Berkovitz | last4 = Sharma | first4 = Arti | author-link4 = | last5 = Reddy | first5 = Venkat | author-link5 = Venkat Reddy | last6 = Leandro | first6 = Maria | author-link6 = Maria Leandro | last7 = Cambridge | first7 = Geraldine| author-link8 = Geraldine Cambridge | title = Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study | journal = Clinical and Experimental Immunology | volume = 184 | issue = 2 | page = 237-247 | date = 2016 | pmid = | doi = 10.1111/cei.12749 }}</ref>
| journal = Clinical and Experimental Immunology     | volume = 172   | issue = 1   | page = 73–80
| date   = 2013
| pmid   =  
| doi     = 10.1111/cei.12043
}}
</ref>
<ref name="Mensah, 2016">{{Citation |last1   = Mensah |first    1  |authorlink1 = Fane Mensah |last2   = Bansal |first    2  |authorlink2 = Amolak Bansal  
| last3   = Berkovitz | first3 = Saul       | authorlink3 = Saul Berkovitz |last4   = Sharma |first    4  |authorlink4 = |last5   = Reddy |first      5  |authorlink5 = Venkat Reddy |last6   = Leandro |first    6  |authorlink6 = Maria Leandro
| last7   = Cambridge | first7 = Geraldine   | authorlink7 = Geraldine Cambridge
| title   = Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study
| journal = Clinical and Experimental Immunology     | volume = 184   | issue = 2   | page = 237-247
| date   = 2016
| pmid   =  
| doi     = 10.1111/cei.12749
}}
</ref>
</references>
</references>


Latest revision as of 17:55, April 1, 2023

B cell shedding Epstein-Barr virus

B cells, also known as B lymphocytes, are a type of white blood cell. They function in the humoral immunity component of the adaptive immune system by secreting antibodies.

Chronic fatigue syndrome[edit | edit source]

Notable studies[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749
  2. ↑ Bradley, AS; Ford, B; Bansal, Amolak (2013), "Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls", Clinical and Experimental Immunology, 172 (1): 73–80, doi:10.1111/cei.12043

B cell B lymphocyte, or a type of white blood cell, which is involved in the immune response by secreting antibodies to ward off infections. In mammals, they are mostly matured in the bone marrow.

B cell B lymphocyte, or a type of white blood cell, which is involved in the immune response by secreting antibodies to ward off infections. In mammals, they are mostly matured in the bone marrow.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

B cell B lymphocyte, or a type of white blood cell, which is involved in the immune response by secreting antibodies to ward off infections. In mammals, they are mostly matured in the bone marrow.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

double blinded trial A clinical trial is double blinded if neither the participants nor the researchers know which treatment group they are allocated to until after the results are interpreted. This reduces bias. (Learn more: www.nottingham.ac.uk)

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=B_cell&oldid=233187"